Income Statement
IOVANCE BIOTHERAPEUTICS, INC.
IOVA
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2013 2013 FY | Dec 31, 2012 2012 FY | Dec 31, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue
|
263.50 | 164.07 | 1.20 | - | - | - | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - |
|
Cost of Revenue
|
173.18 | 124.00 | 10.76 | - | - | - | - | - | - | - | - | - | - | - | - |
|
Gross Profit
|
90.32 | 40.08 | -9.56 | - | - | - | - | - | - | - | - | - | - | - | - |
|
Operating Expenses
|
-914.80 | 435.35 | 450.99 | 398.88 | 342.70 | 261.94 | 206.87 | 128.26 | 92.88 | 53.64 | 27.86 | 12.04 | 22.64 | 8.13 | 21.22 |
|
Research & Development
|
300.27 | 282.34 | 344.08 | 294.78 | 259.04 | 201.73 | 166.02 | 99.83 | 71.62 | 28.04 | 15.47 | 2.70 | 1.33 | 1.66 | 1.76 |
|
Selling, General & Administrative
|
152.32 | 153.02 | 106.92 | 104.10 | 83.66 | 60.21 | 40.85 | 28.43 | 21.26 | 25.60 | 12.39 | - | - | - | - |
|
Other Operating Expenses
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Operating Income
|
-362.27 | -395.28 | -460.55 | -398.88 | -342.70 | -261.94 | -206.87 | -128.26 | -92.88 | -53.64 | -27.86 | -12.04 | -22.64 | -8.13 | -21.22 |
|
Non-Operating Income
|
30.78 | -20.27 | -13.03 | - | - | - | - | - | - | - | - | - | - | - | - |
|
Interest Income
|
10.31 | 20.27 | 13.04 | 2.99 | 0.45 | 2.36 | 9.32 | 4.68 | 0.81 | 0.75 | - | - | - | - | - |
|
Interest Expense
|
- | - | - | - | - | - | - | - | - | - | - | -0.01 | - | 1.92 | 0.15 |
|
Other Non-Op Income / Expense
|
- | - | - | - | - | - | - | - | - | - | 0.20 | 0.01 | -2.74 | 4.82 | -4.48 |
|
Income Before Tax
|
-393.05 | -375.01 | -447.52 | - | - | - | - | - | - | - | - | - | - | - | - |
|
Income Tax Expense
|
-2.07 | -2.83 | -3.48 | - | - | - | - | - | - | - | - | - | - | - | - |
|
Non-Controlling Interest
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Net Income
|
-390.98 | -372.18 | -444.04 | -395.89 | -342.25 | -259.58 | -197.56 | -123.58 | -92.06 | -52.89 | -27.66 | -12.03 | -25.38 | -3.31 | -25.69 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2013 2013 FY | Dec 31, 2012 2012 FY | Dec 31, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-326.34 | -383.28 | -448.95 | -389.57 | -339.59 | -260.80 | -205.70 | -127.30 | -91.93 | -52.66 | -26.86 | -11.95 | -22.63 | -8.13 | -21.22 |
|
Earnings Per Share (Basic)
|
-1.09 | -1.28 | -1.89 | -2.49 | -2.23 | - | - | - | - | - | - | - | - | - | - |
|
Diluted EPS
|
-1.09 | -1.28 | -1.89 | -2.49 | -2.23 | - | - | - | - | - | - | - | - | - | - |
|
Weighted Average Shares
|
0.36 | 0.29 | 0.24 | 0.16 | 0.15 | - | - | - | - | - | - | - | - | - | - |
|
Diluted Weighted Avg Shares
|
0.36 | 0.29 | 0.24 | 0.16 | 0.15 | - | - | - | - | - | - | - | - | - | - |
|
Comprehensive Income
|
-373.49 | -375.75 | -440.61 | -396.19 | -342.87 | -259.78 | -197.29 | -123.62 | -92.09 | -52.91 | -27.61 | - | - | - | - |